Skip to main content
FlashPoint News
HealthA federal vaccine advisory committee is set to discuss altering the recommendation for newborns to receive the hepatitis B vaccine at birth, a decision that could contradict decades of public health guidance. The impact of this potential change raises concerns among health professionals regarding increased hepatitis B infections and deaths among children.

Federal Committee Considers Changes to Newborn Hepatitis B Vaccine Recommendations

A federal advisory panel is set to review whether newborns should receive the hepatitis B vaccine at birth, a move that contradicts existing public health guidelines. Experts and pediatricians warn against delaying this crucial vaccination.

Source: AP1 min read

In brief

The Advisory Committee on Immunization Practices (ACIP), led by Health Secretary Robert F. Kennedy Jr., is expected to discuss potential changes to the recommendation of administering the hepatitis B vaccine to newborns within the first 24 hours of birth. The existing guidelines have been in place for decades, advocating for immediate vaccination to combat hepatitis B, a serious liver infection that can cause chronic diseases and ultimately liver cancer. Critics express concern that altering the vaccination timeline could result in increased infections among infants and threaten public health successes achieved over the past 30 years.

NEW YORK (AP) — A federal vaccine advisory committee is set to evaluate whether to alter the recommendation that newborns receive the hepatitis B vaccine within their first day of life. Currently, guidelines suggest that every infant be vaccinated against this serious liver infection, which can lead to cancer. Health Secretary Robert F. Kennedy Jr.'s committee may oppose decades of public health advice.

The deliberations come as the American Academy of Pediatrics continues to advocate for the birth dose of the vaccine, emphasizing its life-saving potential. Dr. Sean O’Leary stated, We are going to continue to recommend it because it saves lives.

Hepatitis B remains a significant health threat, with about 2.4 million people in the U.S. estimated to be infected — many without knowing it. Infants who contract the virus have a 90% chance of developing chronic infections, which can lead to severe liver complications later in life.

The hepatitis B vaccine has been credited with significant declines in infection rates among children since its introduction. However, the current committee, which includes members with anti-vaccine sentiments, has raised concerns regarding the timing of the vaccination. Suggestions that delaying the dose could impact trust in medical procedures have emerged, alongside warnings of potential increases in infections if the birth dose is postponed.

As discussions unfold, many health officials warn that changes to the recommendations could have detrimental effects on public health and express confusion and concern among parents and healthcare providers. U.S. Sen. Patty Murray has also called for further Congressional scrutiny into ACIP's upcoming actions on this matter.

Topics

More on this story